IntrinsicIntrinsic
← All summaries

Baldwin Insurance Group, Inc.

BWIN
Financials & Chart →

Business Summary

The Baldwin Insurance Group, Inc. (Baldwin) operates as an independent insurance distribution firm, providing expertise and insights in risk management, insurance, and employee benefits. The company's core products include commercial property and casualty insurance, employee benefits insurance, personal lines insurance, wealth management and retirement services, and Medicare. Baldwin competes on reputation, client service, industry insights, product offerings, and tailoring services to client needs. The insurance brokerage industry, while experiencing consolidation, remains highly fragmented, which Baldwin views as an opportunity for further acquisitions. The company serves over three million clients across the United States and internationally, with approximately 5,000 colleagues and 125 offices in 24 states .

Baldwin's business model is centered on generating revenue through commissions and fees by facilitating arrangements between insurance/reinsurance company partners and clients. Revenue streams include core commissions, profit-sharing commissions, consulting and service fees, policy and installment fees, and earned premiums from its Captive business. The company also earns investment income. A significant portion of its core commissions and fees, approximately 17% , is derived from two insurance company partners in 2025. The company's growth strategy involves both organic growth, driven by winning new business, expanding insurance solutions, and increasing economic capture, and inorganic growth through strategic partnerships .

The company's operations are divided into three reportable segments: Insurance Advisory Solutions (IAS), Underwriting, Capacity & Technology Solutions (UCTS), and Mainstreet Insurance Solutions (MIS). IAS focuses on commercial risk management, employee benefits, and private risk management solutions for businesses and high-net-worth individuals. UCTS comprises MSI (a Managing General Agent platform for proprietary, technology-enabled insurance products), a Capacity Solutions group (including reinsurance brokerage, reinsurance MGA, and captive management), and the Captive business. MIS offers personal, commercial, and life and health solutions to individuals and businesses, with a focus on sheltered distribution channels and government assistance programs like Medicare .

In the fiscal year ended December 31, 2025, IAS generated total revenues of $727.324 million , an increase of 2% year-over-year. Core commissions and fees for IAS were $661.590 million , growing by $20.304 million or 3% , primarily due to organic growth. Profit-sharing and other income for IAS decreased by $3.487 million to $61.384 million , a 5% decline . Operating income for IAS was $56.300 million , a 20% increase from the prior year.

UCTS reported total revenues of $549.452 million for the year ended December 31, 2025, representing a 16% increase year-over-year. Core commissions and fees for UCTS grew by $71.400 million , or 16% , to $527.245 million , driven by MSI outperformance ($41.2 million ), the introduction of the Captive ($22.6 million ), and momentum in the Capacity Solutions group ($13.9 million ). Profit-sharing and other income for UCTS increased by $4.313 million , or 33% , to $17.345 million . UCTS operating income increased by 46% to $72.221 million .

MIS generated total revenues of $297.747 million in 2025, a 6% increase from the previous year. Core commissions and fees for MIS increased by $14.458 million , or 6% , to $265.283 million . This growth was primarily attributed to the recently acquired Hippo's Homebuilder Distribution Network ($15.8 million ), the national mortgage and real estate channel ($2.6 million ), and the Westwood business ($1.5 million ), partially offset by a decrease in the Medicare business ($5.0 million ). Profit-sharing and other income for MIS increased by $1.842 million , or 6% , to $32.265 million . Operating income for MIS decreased by 15% to $35.806 million .

For the fiscal year ended December 31, 2025, Baldwin reported total revenues of $1.504 billion , an 8% increase from $1.389 billion in 2024. Core commissions and fees grew by $114.265 million , or 9% , to $1.383 billion . Profit-sharing and other income increased by $2.299 million , or 2% , to $110.625 million . Total operating expenses for 2025 were $1.430 billion , an 8% increase from $1.328 billion in 2024. This resulted in an operating income of $73.936 million , up 22% from $60.648 million in 2024. The company reported a net loss of $54.154 million , or a $0.50 loss per fully diluted share , compared to a net loss of $41.081 million , or a $0.39 loss per fully diluted share , in 2024. Adjusted EBITDA for 2025 was $341.472 million , an increase of $29.0 million year-over-year, with an adjusted EBITDA margin of 22.7% , a 20 basis point expansion . Adjusted net income was $198.942 million , up $22.0 million year-over-year, and adjusted diluted EPS was $1.67 , an 11% increase from $1.50 in 2024. Organic revenue for 2025 was $1.470 billion , with organic revenue growth of $100.049 million , or 7% .

Year-over-year, total revenues increased by $115.847 million , or 8% . Colleague compensation and benefits increased by $15.312 million , or 2% , to $777.531 million . Outside commissions increased by $9.882 million , or 4% , to $279.711 million . Other operating expenses rose by $47.916 million , or 25% , to $240.282 million , driven by higher incurred losses and loss adjustment expense of $19.1 million related to the Captive business, professional fees of $14.0 million , technology and software-related costs of $4.4 million , advertising and marketing of $3.6 million , legal settlement expense of $2.1 million , and licenses and taxes of $2.1 million . Amortization expense increased by $18.586 million , or 18% , to $121.316 million . Interest expense, net, decreased by $2.216 million , or 2% , to $121.428 million . The company reported a loss on extinguishment and modification of debt of $6.226 million in 2025, compared to $15.113 million in 2024.

During 2025, Baldwin launched two new middle-market oriented commercial lines products within its MGA product suite and maintains a pipeline of new programs across personal, commercial, and professional lines, with several slated for launch in 2026 . In January 2025, the company received final approval and a Certificate of Authority from the Texas Department of Insurance to form a Texas-domiciled reciprocal insurance exchange, which began writing business late in the second quarter of 2025 . The third-party led capitalization of the Reciprocal closed and funded in full on May 6, 2025 . Effective April 1, 2025, Baldwin partnered with MultiStrat Group, a Bermuda-based reinsurance underwriting platform, to source alternative reinsurance capital . Effective July 1, 2025, the company acquired Hippo's Homebuilder Distribution Network, enhancing its ability to deliver property and casualty insurance solutions to homebuilder clients . The Wholesale Business, operating within UCTS, was sold on March 1, 2024, for proceeds of approximately $58.9 million , resulting in a pre-tax gain of $35.1 million .

Business Outlook

Management anticipates interest expense to grow in the near term on a year-over-year basis due to higher borrowings under the JPM Credit Facility to fund partnership opportunities and the settlement of deferred payment obligations, although this will be slightly offset by lower expected average interest rates . The company expects rate softness in the insurance market to continue into 2026, particularly in commercial property lines .

A major growth area for Baldwin is its partnership strategy, which has contributed meaningful inorganic growth and is expected to remain active and opportunistic . On January 1, 2026, the company completed a partnership with CAC Group, a nationally recognized specialty and middle-market insurance brokerage firm . This transaction involved aggregate consideration of $438.0 million in cash and 23,200,000 shares of Class A common stock . The purchase consideration also includes a deferred payment of $70.0 million in cash, payable upon the fourth anniversary of the closing date, and a contingent earnout of up to $250.0 million based on certain post-closing revenue-focused performance measures . This partnership is expected to significantly expand the specialty capabilities of the IAS operating group and strengthen its specialty product lines and data and analytics platform .

Another key growth area is the continued investment in existing businesses to drive organic growth, primarily through winning new business, offering a broader array of insurance solutions in an expanded geographic footprint, and capturing a larger portion of insurance sale economics . The company has invested heavily in sales leadership infrastructure, recruitment of sales and technology talent, and solutions to better deliver insurance insights to risk advisors and clients . The MSI platform continues to deliver proprietary and technology-enabled insurance solutions, providing speed, ease of use, and certainty of execution to risk advisors and external distribution partners, while enhancing Baldwin's share of economics . In 2025, the company launched two new middle-market oriented commercial lines products and maintains a pipeline of new programs across personal, commercial, and professional lines, with several slated to launch in 2026 .

Operationally, Baldwin expects a general rise in colleague compensation and benefits expense commensurate with expected revenue growth, as compensation arrangements with colleagues and risk advisors include significant bonus or commission components tied to operating results . The company also operates in competitive markets for human capital and needs to maintain competitive compensation levels as it expands geographically and creates new products and services . The company is implementing a $3B/30 Catalyst Program, designed to accelerate the infusion of automation, business process optimization, and artificial intelligence to transform and elevate its workforce and unlock new avenues for growth .

The company's primary liquidity needs for the foreseeable future include cash to provide capital for organic growth and future partnerships, pay operating expenses (including cash compensation and public company expenses), make payments under the Tax Receivable Agreement, pay interest and principal on borrowings under the JPM Credit Facility and Senior Secured Notes, pay contingent earnout liabilities, pay income taxes, and fund potential investments in third-party businesses . The Board of Directors has authorized the repurchase of up to $250 million of outstanding common stock .

Management has flagged several structural headwinds and execution risks. Organic growth in IAS was pressured by 380 bps of headwind in underlying rate and exposure during 2025, attributable to softening insurance rates, particularly in the property line of business, construction project work weakness, and overall lower economic activity . MIS core commissions and fees growth was negatively impacted by headwinds in the health business and continued pressure in the legacy Mainstreet business . Effective May 1, 2025, MIS is receiving reduced commissions from QBE Insurance Corporation and its affiliates on a portion of its builder-sourced homeowners book of business being migrated to the Reciprocal, a temporary headwind expected to persist through the first half of 2026 before reversing into a tailwind .

Risk Factors

Baldwin faces material risks including insufficient cash flows to service indebtedness, pay contingent earnout liabilities, or finance working capital needs, potentially forcing asset sales or operational curtailment. The company has approximately $1.7 billion in total consolidated debt outstanding as of December 31, 2025, with debt servicing costs of $279.1 million in 2025, including $163.2 million in principal repayments and $115.3 million in interest payments. An additional $600.0 million of incremental term B loans were incurred on January 2, 2026, increasing indebtedness. Macroeconomic conditions, such as inflation and rising interest rates, can reduce demand for services, increase operating expenses (including compensation and rent escalations in leases that expire through August 2035 ), and impact profitability. Volatility or declines in insurance premiums and commission rates, which are set by insurance company partners, can seriously undermine profitability, especially given that contingent commissions have generally ranged from 6.5% to 8.5% of total core commissions and fees over the last two years. The company's business is highly concentrated in the Southeastern U.S., with two insurance company partners accounting for approximately 17% of total core commissions and fees in 2025, making it vulnerable to regional economic downturns, natural disasters, or regulatory changes. The inability to effectively apply technology, including artificial intelligence, or to retain and hire qualified colleagues, including executive officers, could negatively impact reputation and business generation. Partnerships, while important for growth, carry risks of unsuccessful integration, unforeseen liabilities, and failure to achieve anticipated benefits. The company also faces risks of impairment of goodwill, which stood at $1.5 billion as of December 31, 2025, representing 39% of total assets. Regulatory non-compliance, E&O claims, and cybersecurity incidents pose significant legal and financial liabilities, with potential for fines, penalties, and reputational harm. The marketing and sale of Medicare plans are subject to numerous, complex, and frequently changing laws and regulations, with non-compliance potentially leading to termination of insurance company partner relationships or loss of commissions.

Management Priorities

Management's message to shareholders emphasizes a strategy centered on reinvesting retained earnings into future growth, aiming to produce sustainable results for all stakeholders, including clients, colleagues, insurance company partners, communities, and stockholders. The company believes this approach will lead to increased value for stockholders through revenue growth and margin accretion over time, generating significant adjusted free cash flow. Management is pursuing a two-pronged growth approach: meaningful investment in existing businesses to drive organic growth and inorganic growth through strategic partnerships. They highlight continued investment in sales leadership, recruitment of talent, and technology solutions, including the MSI platform, to enhance service delivery and capture a greater share of insurance economics. Management explicitly states that organic growth will be driven by winning new business, expanding insurance solutions, and increasing geographic footprint. The company's partnership strategy is described as active and opportunistic, focusing on high-quality, fast-growing independent firms, with a differentiated value proposition that includes retained business decision-making autonomy and leadership opportunities for new partners. Management notes the completion of 37 partnerships since the beginning of 2020, acquiring $909.0 million of revenue, including nine "Top 100" firms. They also highlight the recent partnership with CAC Group on January 1, 2026, which involved $438.0 million in cash and 23,200,000 shares of Class A common stock, with a deferred payment of $70.0 million and a contingent earnout of up to $250.0 million . Management expects interest expense to grow in the near term due to higher borrowings under the JPM Credit Facility to fund partnership opportunities and deferred payment obligations, offset slightly by lower expected average interest rates .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business
  2. [2] Item 1, Business
  3. [3] Item 1, Business
  4. [4] Item 1, Business
  5. [5] Item 1, Business
  6. [6] Item 1, Business
  7. [7] Item 1, Business
  8. [8] Item 1, Business
  9. [9] Item 1, Business Strategy
  10. [10] Item 1, Operating Groups
  11. [11] Item 7, MD&A — Executive Summary of 2025 Financial Results
  12. [12] Item 7, MD&A — Results of Operations for the Years Ended December 31, 2025 and 2024
  13. [13] Item 7, MD&A — Executive Summary of 2025 Financial Results
  14. [14] Item 7, MD&A — Executive Summary of 2025 Financial Results
  15. [15] Item 7, MD&A — Executive Summary of 2025 Financial Results
  16. [16] Item 7, MD&A — Executive Summary of 2025 Financial Results
  17. [17] Item 7, MD&A — Colleague Compensation and Benefits
  18. [18] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  19. [19] Item 7, MD&A — Other Operating Expenses
  20. [20] Item 7, MD&A — Interest Expense, Net
  21. [21] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  22. [22] Item 7, MD&A — Recent Developments
  23. [23] Item 7, MD&A — Recent Developments
  24. [24] Item 7, MD&A — Recent Developments
  25. [25] Item 7, MD&A — Recent Developments
  26. [26] Item 7, MD&A — Recent Developments
  27. [27] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  28. [28] Item 1, Clients and Insurers
  29. [29] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  30. [30] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  31. [31] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  32. [32] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  33. [33] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  34. [34] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  35. [35] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  36. [36] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  37. [37] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  38. [38] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  39. [39] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  40. [40] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  41. [41] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  42. [42] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  43. [43] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  44. [44] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  45. [45] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  46. [46] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  47. [47] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  48. [48] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  49. [49] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  50. [50] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  51. [51] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  52. [52] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  53. [53] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  54. [54] Item 1A, Risk Factors — Risks Relating to our Business Operations and Industry
  55. [55] Item 7, MD&A — Executive Summary of 2025 Financial Results
  56. [56] Item 7, MD&A — Executive Summary of 2025 Financial Results
  57. [57] Item 7, MD&A — Executive Summary of 2025 Financial Results
  58. [58] Item 7, MD&A — Colleague Compensation and Benefits
  59. [59] Item 7, MD&A — Colleague Compensation and Benefits
  60. [60] Item 7, MD&A — Colleague Compensation and Benefits
  61. [61] Item 7, MD&A — Adjusted EBITDA and Adjusted EBITDA Margin
  62. [62] Item 7, MD&A — Liquidity and Capital Resources
  63. [63] Item 7, MD&A — Insurance Advisory Solutions Operating Group Results
  64. [64] Item 7, MD&A — Insurance Advisory Solutions Operating Group Results
  65. [65] Item 7, MD&A — Underwriting, Capacity & Technology Solutions Operating Group Results
  66. [66] Item 7, MD&A — Underwriting, Capacity & Technology Solutions Operating Group Results
  67. [67] Item 7, MD&A — Mainstreet Insurance Solutions Operating Group Results
  68. [68] Item 7, MD&A — Mainstreet Insurance Solutions Operating Group Results
  69. [69] Item 7, MD&A — Liquidity and Capital Resources
  70. [70] Item 7, MD&A — Liquidity and Capital Resources
  71. [71] Item 7, MD&A — Contractual Obligations and Commitments
  72. [72] Item 7, MD&A — Contractual Obligations and Commitments
  73. [73] Item 7, MD&A — Contractual Obligations and Commitments
  74. [74] Item 7, MD&A — Contractual Obligations and Commitments
  75. [75] Item 7, MD&A — Contractual Obligations and Commitments
  76. [76] Item 7, MD&A — Contractual Obligations and Commitments
  77. [77] Item 7, MD&A — Contractual Obligations and Commitments
  78. [78] Item 7, MD&A — Contractual Obligations and Commitments
  79. [79] Item 7, MD&A — Contractual Obligations and Commitments
  80. [80] Item 7, MD&A — Contractual Obligations and Commitments
  81. [81] Item 7, MD&A — Contractual Obligations and Commitments
  82. [82] Item 7, MD&A — Contractual Obligations and Commitments
  83. [83] Item 7, MD&A — Contractual Obligations and Commitments
  84. [84] Item 7, MD&A — Contractual Obligations and Commitments
  85. [85] Item 7, MD&A — Contractual Obligations and Commitments
  86. [86] Item 7, MD&A — Contractual Obligations and Commitments
  87. [87] Item 7, MD&A — Contractual Obligations and Commitments
  88. [88] Item 7, MD&A — Contractual Obligations and Commitments
  89. [89] Item 7, MD&A — Contractual Obligations and Commitments
  90. [90] Item 7, MD&A — Contractual Obligations and Commitments
  91. [91] Item 7, MD&A — Contractual Obligations and Commitments
  92. [92] Item 7, MD&A — Contractual Obligations and Commitments
  93. [93] Item 7, MD&A — Contractual Obligations and Commitments
  94. [94] Item 7, MD&A — Contractual Obligations and Commitments
  95. [95] Item 7, MD&A — Contractual Obligations and Commitments
  96. [96] Item 7, MD&A — Contractual Obligations and Commitments
  97. [97] Item 7, MD&A — Contractual Obligations and Commitments
  98. [98] Item 7, MD&A — Contractual Obligations and Commitments
  99. [99] Item 7, MD&A — Contractual Obligations and Commitments
  100. [100] Item 7, MD&A — Contractual Obligations and Commitments
  101. [101] Item 7, MD&A — Contractual Obligations and Commitments
  102. [102] Item 3, Business Combinations
  103. [103] Item 3, Business Combinations
  104. [104] Item 4, Business Divestitures
  105. [105] Item 4, Business Divestitures

Analysis on 5/20/2026